| Drug Name | Ilanris (canakinumab) |
|---|---|
| Drug Class |
Immunosuppressant
|
| Risk minimization type |
Patient Card
|
| Specialty (Theraputic area) |
Rheumatology
|
| Risk |
Infections, Opportunistic infections, Neutropenia, Drug induced liver injury (DILI, hepatic transaminase and bilirubin elevations) (for Still’s disease), Decreased estimated creatinine clearance and proteinuria (for Still’s disease), Musculoskeletal pain and arthralgia (for Still’s disease) |
| Patient card |
|